The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
Cytokines as biomarkers of nanoparticle immunotoxicity
Open accessAbstract
Nanoscale objects, whether of biologic origin or synthetically created, are being developed into devices for a variety of bionanotechnology diagnostic and pharmaceutical applications. However, the potential immunotoxicity of these nanomaterials and mechanisms by which they may induce adverse reactions have not received sufficient attention. Nanomaterials, depending on their characteristics and compositions, can interact with the immune system in several ways and either enhance or suppress immune system function. Cytokines perform pleiotropic functions to mediate and regulate the immune response and are generally recognized as biomarkers of immunotoxicity. While the specificity and validity of certain cytokines as markers of adverse immune response has been established for chemicals, small and macromolecular drugs, research on their applicability for predicting and monitoring the immunotoxicity of engineered nanomaterials is still ongoing. The goal of this review is to provide guidelines as to important cytokines that can be utilized for evaluating the immunotoxicity of nanomaterials and to highlight the role of those cytokines in mediating adverse reactions, which is of particular importance for the clinical development of nanopharmaceuticals and other nanotechnology-based products. Importantly, the rational design of nanomaterials of low immunotoxicity will be discussed, focusing on synthetic nanodevices, with emphasis on both the nanoparticle-forming materials and the embedded cargoes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Elsabahy, M., Wazen, N., Bayó‐Puxán, N., Deleavey, G. F., Servant, M. J., Damha, M. J., & Leroux, J. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200901139 · Cited by 62
Self-citationRetractedToxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
The Nuclear Factor NF- B Pathway in Inflammation
Lawrence, T. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001651 · Cited by 4,898
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
Poland, C. A., Duffin, R., Kinloch, I., Maynard, A., Wallace, W. A. H., Seaton, A., Stone, V., Brown, S., MacNee, W., & Donaldson, K. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.111 · Cited by 2,645
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Signaling to NF-κB by Toll-like receptors
Kawai, T., & Akira, S. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.09.002 · Cited by 2,388
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Micellar Nanocarriers: Pharmaceutical Perspectives
Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Design of polymeric nanoparticles for biomedical delivery applications
Elsabahy, M., & Wooley, K. L. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15327k · Cited by 1,717
Self-citationImmunological aspects of cancer chemotherapy
Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2216 · Cited by 1,712
Block copolymer micelles: preparation, characterization and application in drug delivery
Gaucher, G., Dufresne, M.-H., Sant, V. P., Kang, N., Maysinger, D., & Leroux, J.-C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.034 · Cited by 1,498
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice
Shvedova, A. A., Kisin, E. R., Mercer, R., Murray, A. R., Johnson, V. J., Potapovich, A. I., Tyurina, Y. Y., Gorelik, O., Arepalli, S., Schwegler-Berry, D., et al. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00084.2005 · Cited by 1,312
Nanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Iversen, T.-G., Skotland, T., & Sandvig, K. (2011) · Nano Today · doi:10.1016/j.nantod.2011.02.003 · Cited by 1,239
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168
Kim, B. Y. S., Rutka, J. T., & Chan, W. C. W. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912273 · Cited by 1,147
Liu, Z., Davis, C., Cai, W., He, L., Chen, X., & Dai, H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707654105 · Cited by 1,116
Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.
Kidd, P. M. (2003) · PubMed · Cited by 1,102
DNA vaccines: ready for prime time?
Kutzler, M. A., & Weiner, D. B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2432 · Cited by 1,077
Functionalized Carbon Nanotubes in Drug Design and Discovery
Prato, M., Kostarelos, K., & Bianco, A. (2008) · Accounts of Chemical Research · doi:10.1021/ar700089b · Cited by 1,059
Nishiyama, N., & Kataoka, K. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.006 · Cited by 1,052
Dobrovolskaia, M. A., Aggarwal, P., Hall, J. B., & McNeil, S. E. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800032f · Cited by 1,022
PULSKAMP, K., DIABATE, S., & KRUG, H. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2006.11.001 · Cited by 1,004
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974
The Role of Nuclear Factor- κ B in Cytokine Gene Regulation
Blackwell, T. S., & Christman, J. W. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.1.f132 · Cited by 955
Minireview: Nanoparticles and the Immune System
Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation
Deng, Z. J., Liang, M., Monteiro, M., Toth, I., & Minchin, R. F. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2010.250 · Cited by 893
Protein nanoparticles as drug carriers in clinical medicine
Hawkins, M. J., Soon-Shiong, P., & Desai, N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.044 · Cited by 779
Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.
Beutler, B. A., Milsark, I. W., & Cerami, A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.3972 · Cited by 763
Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors
Fifis, T., Gamvrellis, A., Crimeen-Irwin, B., Pietersz, G. A., Li, J., Mottram, P. L., McKenzie, I. F. C., & Plebanski, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3148 · Cited by 664
Toll-Like Receptors: Linking Innate and Adaptive Immunity
Pasare, C., & Medzhitov, R. (2005) · Advances in Experimental Medicine and Biology · doi:10.1007/0-387-24180-9_2 · Cited by 660
The role of Th1/Th2 polarization in mucosal immunity
Neurath, M. F., Finotto, S., & Glimcher, L. H. (2002) · Nature Medicine · doi:10.1038/nm0602-567 · Cited by 623
Inorganic nanoparticles for cancer imaging and therapy
Huang, H.-C., Barua, S., Sharma, G., Dey, S. K., & Rege, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.004 · Cited by 618
Beating cancer in multiple ways using nanogold
Dreaden, E. C., Mackey, M. A., Huang, X., Kang, B., & El-Sayed, M. A. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00180e · Cited by 605
Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in Vivo
Judge, A. D., Bola, G., Lee, A. C. H., & MacLachlan, I. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.002 · Cited by 571
Multiplex bead array assays: Performance evaluation and comparison of sensitivity to ELISA☆
ELSHAL, M., & MCCOY, J. (2006) · Methods · doi:10.1016/j.ymeth.2005.11.010 · Cited by 568
In vitro assessments of nanomaterial toxicity
Jones, C. F., & Grainger, D. W. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.005 · Cited by 554
Nanotoxicology and in vitro studies: The need of the hour
Arora, S., Rajwade, J. M., & Paknikar, K. M. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.11.010 · Cited by 537
ELISA and Multiplex Technologies for Cytokine Measurement in Inflammation and Aging Research
Leng, S. X., McElhaney, J. E., Walston, J. D., Xie, D., Fedarko, N. S., & Kuchel, G. A. (2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.8.879 · Cited by 516
Warheit, D. B., Webb, T. R., Sayes, C. M., Colvin, V. L., & Reed, K. L. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj140 · Cited by 508
Nanoparticles that communicate in vivo to amplify tumour targeting
Park, J., Lin, K., Singh, N., Schwöppe, C., Mesters, R. M., Berdel, W. E., Ruoslahti, E. I., Sailor, M. J., von Maltzhan, G., & Bhatia, S. N. (2010) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 500
pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates
Felber, A. E., Dufresne, M.-H., & Leroux, J.-C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.006 · Cited by 478
Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation
Shi, J., Xiao, Z., Kamaly, N., & Farokhzad, O. C. (2011) · Accounts of Chemical Research · doi:10.1021/ar200054n · Cited by 476
Monteiller, C., Tran, L., MacNee, W., Faux, S., Jones, A., Miller, B., & Donaldson, K. (2007) · Occupational and Environmental Medicine · doi:10.1136/oem.2005.024802 · Cited by 474
Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery
Li, J., Chen, Y.-C., Tseng, Y.-C., Mozumdar, S., & Huang, L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.008 · Cited by 470
Current in vitro methods in nanoparticle risk assessment: Limitations and challenges
Kroll, A., Pillukat, M. H., Hahn, D., & Schnekenburger, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.009 · Cited by 465
Up‐regulation of cytokines and chemokines predates the onset of rheumatoid arthritis
Kokkonen, H., Söderström, I., Rocklöv, J., Hallmans, G., Lejon, K., & Rantapää Dahlqvist, S. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27186 · Cited by 454
Karikó, K., Bhuyan, P., Capodici, J., & Weissman, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6545 · Cited by 449
Polymer-drug conjugates: Recent development in clinical oncology
Li, C., & Wallace, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.009 · Cited by 436
Alton, E., Stern, M., Farley, R., Jaffe, A., Chadwick, S., Phillips, J., Davies, J., Smith, S., Browning, J., Davies, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06532-5 · Cited by 435
Chemically modified siRNA: tools and applications
Watts, J. K., Deleavey, G. F., & Damha, M. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.05.007 · Cited by 431
Development of in vitro systems for nanotoxicology: methodological considerations
Stone, V., Johnston, H., & Schins, R. P. F. (2009) · Critical Reviews in Toxicology · doi:10.1080/10408440903120975 · Cited by 427
Analytical methods to assess nanoparticle toxicity
Marquis, B. J., Love, S. A., Braun, K. L., & Haynes, C. L. (2009) · The Analyst · doi:10.1039/b818082b · Cited by 406
Renwick, L. C., Brown, D., Clouter, A., & Donaldson, K. (2004) · Occupational and Environmental Medicine · doi:10.1136/oem.2003.008227 · Cited by 385
Gröne, A. (2002) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(02)00136-8 · Cited by 384
Evaluation of nanoparticle immunotoxicity
Dobrovolskaia, M. A., Germolec, D. R., & Weaver, J. L. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.175 · Cited by 368
Lee, J., Lee, K., Moon, S. H., Lee, Y., Park, T. G., & Cheon, J. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805998 · Cited by 365
Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity
Hamilton, R. F., Wu, N., Porter, D., Buford, M., Wolfarth, M., & Holian, A. (2009) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-6-35 · Cited by 361
SINGH, S., SHI, T., DUFFIN, R., ALBRECHT, C., VANBERLO, D., HOHR, D., FUBINI, B., MARTRA, G., FENOGLIO, I., & BORM, P. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.05.001 · Cited by 359
Ryman-Rasmussen, J. P., Riviere, J. E., & Monteiro-Riviere, N. A. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700508 · Cited by 357
Hussain, S., Boland, S., Baeza-Squiban, A., Hamel, R., Thomassen, L. C. J., Martens, J. A., Billon-Galland, M. A., Fleury-Feith, J., Moisan, F., Pairon, J.-C., et al. (2009) · Toxicology · doi:10.1016/j.tox.2009.04.001 · Cited by 347
Gajewski, T. F., Pinnas, M., Wong, T., & Fitch, F. W. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.6.1750 · Cited by 347
Oxidative stress and inflammatory response in dermal toxicity of single-walled carbon nanotubes
Murray, A. R., Kisin, E., Leonard, S. S., Young, S. H., Kommineni, C., Kagan, V. E., Castranova, V., & Shvedova, A. A. (2009) · Toxicology · doi:10.1016/j.tox.2008.12.023 · Cited by 345
Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice
Judge, A. D., Robbins, M., Tavakoli, I., Levi, J., Hu, L., Fronda, A., Ambegia, E., McClintock, K., & MacLachlan, I. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37515 · Cited by 336
Stebbings, R., Findlay, L., Edwards, C., Eastwood, D., Bird, C., North, D., Mistry, Y., Dilger, P., Liefooghe, E., Cludts, I., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3325 · Cited by 316
CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression
Hyde, S. C., Pringle, I. A., Abdullah, S., Lawton, A. E., Davies, L. A., Varathalingam, A., Nunez-Alonso, G., Green, A.-M., Bazzani, R. P., Sumner-Jones, S. G., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1399 · Cited by 310
Mottram, P. L., Leong, D., Crimeen-Irwin, B., Gloster, S., Xiang, S. D., Meanger, J., Ghildyal, R., Vardaxis, N., & Plebanski, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060096p · Cited by 296
Nuclear Factor-κB in Development, Prevention, and Therapy of Cancer
Van Waes, C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2221 · Cited by 292
The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol
Byrd-Leifer, C. A., Block, E. F., Takeda, K., Akira, S., & Ding, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200108)31:8<2448::aid-immu2448>3.0.co;2-n · Cited by 287
Overcoming the Innate Immune Response to Small Interfering RNA
Judge, A., & MacLachlan, I. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.179 · Cited by 284
Wittmaack, K. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9254 · Cited by 280
Hamdy, S., Molavi, O., Ma, Z., Haddadi, A., Alshamsan, A., Gobti, Z., Elhasi, S., Samuel, J., & Lavasanifar, A. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.035 · Cited by 252
Scheule, R. K., George, J. A. S., Bagley, R. G., Marshall, J., Kaplan, J. M., Akita, G. Y., Wang, K. X., Lee, E. R., Harris, D. J., Jiang, C., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.6-689 · Cited by 251
Veranth, J. M., Kaser, E. G., Veranth, M. M., Koch, M., & Yost, G. S. (2007) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-4-2 · Cited by 251
Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes
ZHANG, L., YU, W., COLVIN, V, & MONTEIRORIVIERE, N. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.12.022 · Cited by 247
Cho, W.-S., Duffin, R., Poland, C. A., Duschl, A., Oostingh, G. J., MacNee, W., Bradley, M., Megson, I. L., & Donaldson, K. (2012) · Nanotoxicology · doi:10.3109/17435390.2011.552810 · Cited by 241
Thomas, C., Rawat, A., Hope-Weeks, L., & Ahsan, F. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100255c · Cited by 241
Vallhov, H., Qin, J., Johansson, S. M., Ahlborg, N., Muhammed, M. A., Scheynius, A., & Gabrielsson, S. (2006) · Nano Letters · doi:10.1021/nl060860z · Cited by 238
Chono, S., Li, S.-D., Conwell, C. C., & Huang, L. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.006 · Cited by 238
Tan, Y., Li, S., Pitt, B. R., & Huang, L. (1999) · Human Gene Therapy · doi:10.1089/10430349950017149 · Cited by 237
Mohanan, D., Slütter, B., Henriksen-Lacey, M., Jiskoot, W., Bouwstra, J. A., Perrie, Y., Kündig, T. M., Gander, B., & Johansen, P. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.012 · Cited by 229
Yang, E.-J., Kim, S., Kim, J. S., & Choi, I.-H. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.016 · Cited by 219
Paclitaxel poliglumex (XYOTAX™, CT-2103): A macromolecular taxane
Singer, J. W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.033 · Cited by 213
Multifunctional Nanoemulsion Platform for Imaging Guided Therapy Evaluated in Experimental Cancer
Gianella, A., Jarzyna, P. A., Mani, V., Ramachandran, S., Calcagno, C., Tang, J., Kann, B., Dijk, W. J. R., Thijssen, V. L., Griffioen, A. W., et al. (2011) · ACS Nano · doi:10.1021/nn103336a · Cited by 212
Abrams, M. T., Koser, M. L., Seitzer, J., Williams, S. C., DiPietro, M. A., Wang, W., Shaw, A. W., Mao, X., Jadhav, V., Davide, J. P., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.208 · Cited by 209
Cubillos-Ruiz, J. R., Engle, X., Scarlett, U. K., Martinez, D., Barber, A., Elgueta, R., Wang, Nesbeth, Y., Durant, Gewirtz, A. T., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37716 · Cited by 208
Yew, N. S., Wang, K. X., Przybylska, M., Bagley, R. G., Stedman, M., Marshall, J., Scheule, R. K., & Cheng, S. H. (1999) · Human Gene Therapy · doi:10.1089/10430349950019011 · Cited by 205
NLRP3 Inflammasome Activation Induced by Engineered Nanomaterials
Sun, B., Wang, X., Ji, Z., Li, R., & Xia, T. (2013) · Small · doi:10.1002/smll.201201962 · Cited by 204
Advances in the field of nanooncology
Jain, K. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-83 · Cited by 203
Delayed type hypersensitivity: Current theories with a historic perspective
Black, C. A. (1999) · Dermatology Online Journal · doi:10.5070/d32fw0g1xx · Cited by 202
Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNA
Li, S.-D., Chono, S., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.51 · Cited by 198
Liu, Y., Jiao, F., Qiu, Y., Li, W., Lao, F., Zhou, G., Sun, B., Xing, G., Dong, J., Zhao, Y., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.001 · Cited by 197
Heng, B. C., Zhao, X., Tan, E. C., Khamis, N., Assodani, A., Xiong, S., Ruedl, C., Ng, K. W., & Loo, J. S.-C. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0722-1 · Cited by 194
Induction of Inflammasome-dependent Pyroptosis by Carbon Black Nanoparticles
Reisetter, A. C., Stebounova, L. V., Baltrusaitis, J., Powers, L., Gupta, A., Grassian, V. H., & Monick, M. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.238519 · Cited by 192
Molecular mechanism of kidney injury of mice caused by exposure to titanium dioxide nanoparticles
Gui, S., Zhang, Z., Zheng, L., Cui, Y., Liu, X., Li, N., Sang, X., Sun, Q., Gao, G., Cheng, Z., et al. (2011) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2011.08.055 · Cited by 191
Ruiz, F. E., Clancy, J. P., Perricone, M. A., Bebok, Z., Hong, J. S., Cheng, S. H., Meeker, D. P., Young, K. R., Schoumacher, R. A., Weatherly, M. R., et al. (2001) · Human Gene Therapy · doi:10.1089/104303401750148667 · Cited by 185
The immune effects of naturally occurring and synthetic nanoparticles
Chang, C. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.009 · Cited by 180
Freimark, B. D., Blezinger, H. P., Florack, V. J., Nordstrom, J. L., Long, S. D., Deshpande, D. S., Nochumson, S., & Petrak, K. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4580 · Cited by 180
Schanen, B. C., Karakoti, A. S., Seal, S., Drake III, D. R., Warren, W. L., & Self, W. T. (2009) · ACS Nano · doi:10.1021/nn900403h · Cited by 175
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
Tacken, P. J., Zeelenberg, I. S., Cruz, L. J., van Hout-Kuijer, M. A., van de Glind, G., Fokkink, R. G., Lambeck, A. J. A., & Figdor, C. G. (2011) · Blood · doi:10.1182/blood-2011-07-367615 · Cited by 173
Javeed, A., Ashraf, M., Riaz, A., Ghafoor, A., Afzal, S., & Mukhtar, M. M. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.08.009 · Cited by 172
Breaking the Bonds: Non-viral Vectors Become Chemically Dynamic
Wolff, J. A., & Rozema, D. B. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300326 · Cited by 163
Interactions of nanomaterials with the immune system
Hussain, S., Vanoirbeek, J., & Hoet, P. (2011) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.166 · Cited by 161
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (2005) · The Journal of Immunology · doi:10.1093/jimmunol/175.1.5 · Cited by 161
The Mode of Action of Taxol: Apoptosis at Low Concentration and Necrosis at High Concentration
Yeung, T. K., Germond, C., Chen, X., & Wang, Z. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1375 · Cited by 160
Dissociation between plasma and monocyte‐associated cytokines during sepsis
Muñoz, C., Misset, B., Fitting, C., Blériot, J. P., Jean‐Carlet, & Cavaillon, J. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210928 · Cited by 156
Synthesis and Characterization of Core–Shell Star Copolymers for In Vivo PET Imaging Applications
Fukukawa, K., Rossin, R., Hagooly, A., Pressly, E. D., Hunt, J. N., Messmore, B. W., & Hawker, C. J. (2008) · Biomacromolecules · doi:10.1021/bm7014152 · Cited by 153
Poly-l-lysine-coated nanoparticles: A potent delivery system to enhance DNA vaccine efficacy
Minigo, G., Scholzen, A., Tang, C. K., Hanley, J. C., Kalkanidis, M., Pietersz, G. A., Apostolopoulos, V., & Plebanski, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.086 · Cited by 151
Carrillo‐Conde, B., Song, E.-H., Chavez-Santoscoy, A. V., Phanse, Y., Ramer‐Tait, A. E., Pohl, N. L. B., Wannemuehler, M. J., Bellaire, B. H., & Narasimhan, B. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200213r · Cited by 147
Nyström, A. M., & Wooley, K. L. (2011) · Accounts of Chemical Research · doi:10.1021/ar200097k · Cited by 146
Self-citationComparison of non-crystalline silica nanoparticles in IL-1β release from macrophages
Sandberg, W. J., Låg, M., Holme, J. A., Friede, B., Gualtieri, M., Kruszewski, M. K., Schwarze, P. E., Skuland, T., & Refsnes, M. (2012) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-9-32 · Cited by 146
The immunological effects of taxanes
Chan, O. T. M., & Yang, L. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620000122 · Cited by 145
Control of infection by pyroptosis and autophagy: role of TLR and NLR
Bortoluci, K., & Medzhitov, R. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0335-5 · Cited by 145
Inoue, K., Takano, H., Yanagisawa, R., Hirano, S., Sakurai, M., Shimada, A., & Yoshikawa, T. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8903 · Cited by 143
Progress in understanding adjuvant immunotoxicity mechanisms
Batista-Duharte, A., Lindblad, E. B., & Oviedo‐Orta, E. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.03.001 · Cited by 143
Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane
Singer, J. W., Shaffer, S. A., Baker, B., Bernareggi, A., Stromatt, S. C., Nienstedt, D., & Besman, M. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200503000-00003 · Cited by 139
Chitosan IFN-γ-pDNA Nanoparticle (CIN) Therapy for Allergic Asthma
Kumar, M., Kong, X., Behera, A. K., Hellermann, G. R., Lockey, R. F., & Mohapatra, S. S. (2003) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-1-3 · Cited by 131
Multi-walled carbon nanotube exposure alters protein expression in human keratinocytes
Witzmann, F. A., & Monteiro-Riviere, N. A. (2006) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.07.005 · Cited by 131
Meunier, É., Coste, A., Olagnier, D. P., Authier, H., Lefèvre, L., Dardenne, C., Bernad, J., Béraud, M., Emmanuel Flahaut, B., & Pipy, B. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.11.004 · Cited by 131
Conway, M. A., Madrigal-Estebas, L., McClean, S., Brayden, D. J., & Mills, K. H. G. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00433-3 · Cited by 130
Toxicity Pathway Focused Gene Expression Profiling of PEI-Based Polymers for Pulmonary Applications
Beyerle, A., Irmler, M., Beckers, J., Kissel, T., & Stoeger, T. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900278x · Cited by 128
Pressly, E. D., Rossin, R., Hagooly, A., Fukukawa, K., Messmore, B. W., Welch, M. J., Wooley, K. L., Lamm, M. S., Hule, R. A., Pochan, D. J., et al. (2007) · Biomacromolecules · doi:10.1021/bm700541e · Cited by 128
Self-citationNano Titanium Dioxide Particles Promote Allergic Sensitization and Lung Inflammation in Mice
Larsen, S. T., Roursgaard, M., Jensen, K. A., & Nielsen, G. D. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00473.x · Cited by 127
Liu, T., Li, L., Fu, C., Liu, H., Chen, D., & Tang, F. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.008 · Cited by 126
Diphtheria toxoid loaded poly-(ε-caprolactone) nanoparticles as mucosal vaccine delivery systems
Singh, J., Pandit, S., Bramwell, V. W., & Alpar, H. O. (2006) · Methods · doi:10.1016/j.ymeth.2005.11.003 · Cited by 122
Sood, A., Salih, S., Roh, D. S., Lacharme‐Lora, L., Parry, M., Hardiman, B., Keehan, R., Grümmer, R., Winterhager, E., Gokhale, P. J., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.188 · Cited by 122
Dobrovolskaia, M. A., Neun, B. W., Clogston, J. D., Ding, H., Ljubimova, J. Y., & McNeil, S. E. (2010) · Nanomedicine · doi:10.2217/nnm.10.29 · Cited by 117
Kim, T. H., Nah, J. W., Cho, M., Park, T. G., & Cho, C. S. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.434 · Cited by 117
RNA interference and innate immunity
Sioud, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.006 · Cited by 116
Intratumoral injection of IL-12 plasmid DNA – results of a phase I/IB clinical trial
Mahvi, D. M., Henry, M. B., Albertini, M. R., Weber, S. M., Meredith, K. L., Schalch, H., Rakhmilevich, A. L., Hank, J. A., & Sondel, P. M. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701064 · Cited by 112
Particle size and activation threshold: a new dimension of danger signaling
Rettig, L., Haen, S. P., Bittermann, A. G., von Boehmer, L., Fontecedro, A. C., Krämer, S. D., Knuth, A. K., & Pascolo, S. (2010) · Blood · doi:10.1182/blood-2009-11-247817 · Cited by 108
Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes
Bedi, D., Musacchio, T., Fagbohun, O. A., Gillespie, J. W., DeInnocentes, P., Bird, R. C., Bookbinder, L., Torchilin, V. P., & Petrenko, V. A. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.10.004 · Cited by 104
Nanosized titanium dioxide enhanced inflammatory responses in the septic brain of mouse
Shin, J. A., Lee, E. J., Seo, S. M., Kim, H. S., Kang, J. L., & Park, E. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.057 · Cited by 103
Highlights of 10 years of immunology in Nature Reviews Immunology
Medzhitov, R. M., Shevach, E. M., Trinchieri, G., Mellor, A. L., Munn, D. H., Gordon, S., Libby, P., Hansson, G. K., Shortman, K., Dong, C., et al. (2011) · Nature reviews. Immunology · doi:10.1038/nri3063 · Cited by 102
Immunostimulation Mechanism of LPD Nanoparticle as a Vaccine Carrier
Cui, Z., Han, S., Vangasseri, D. P., & Huang, L. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049907k · Cited by 101
Val, S., Hussain, S., Boland, S., Hamel, R., Baeza‐Squiban, A., & Marano, F. (2009) · Inhalation Toxicology · doi:10.1080/08958370902942533 · Cited by 101
Elsabahy, M., & Wooley, K. L. (2012) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.25955 · Cited by 97
Self-citationThe mechanism of retinol-induced irritation and its application to anti-irritant development
Kim, B. (2003) · Toxicology Letters · doi:10.1016/j.toxlet.2003.09.001 · Cited by 97
Inhibition ofEscherichia coli-Induced Meningitis by Carboxyfullerence
Tsao, N., Kanakamma, P. P., Luh, T., Chou, C., & Lei, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2273 · Cited by 96
Bølling, A. K., Totlandsdal, A. I., Låg, M., Refsnes, M., & Schwarze, P. E. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2007.10.014 · Cited by 95
Chavez-Santoscoy, A. V., Roychoudhury, R., Pohl, N. L. B., Wannemuehler, M. J., Narasimhan, B., & Ramer‐Tait, A. E. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.027 · Cited by 92
Oxidative Stress and Dermal Toxicity of Iron Oxide Nanoparticles In Vitro
Murray, A. R., Kisin, E. R., Inman, A. O., Young, S., Muhammed, M. A., Burks, T., Uheida, A., Tkach, A. V., Waltz, M. J., Castranova, V., et al. (2012) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-012-9367-9 · Cited by 91
Sun, G., Hagooly, A., Xu, J., Nyström, A. M., Li, Z., Rossin, R., Moore, D. A., Wooley, K. L., & Welch, M. J. (2008) · Biomacromolecules · doi:10.1021/bm800246x · Cited by 89
Self-citationImmune modulation for treatment of allergic disease
Nguyen, T. T., & Casale, T. B. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01034.x · Cited by 88
Cytokine-Release Syndrome: Overview and Nursing Implications
Breslin, S. (2007) · Clinical journal of oncology nursing · doi:10.1188/07.cjon.s1.37-42 · Cited by 85
Stanberry, L. R., Simon, J. K., Johnson, C., Robinson, P. L., Morry, J., Flack, M., Gracon, S. I., Myc, A., Hamouda, T., & Baker, J. R. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.10.094 · Cited by 85
Shrestha, R., Elsabahy, M., Florez-Pollack, S., Samarajeewa, S., & Wooley, K. L. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.054 · Cited by 82
Self-citationA Fibrin-Specific Thrombolytic Nanomedicine Approach to Acute Ischemic Stroke
Marsh, J. N., Hu, G., Scott, M. J., Zhang, H., Goette, M., Gaffney, P. J., Caruthers, S. D., Wickline, S. A., Abendschein, D. R., & Lanza, G. M. (2011) · Nanomedicine · doi:10.2217/nnm.11.21 · Cited by 81
Influence of hydrophobicity on the adjuvant effect of particulate polymeric adjuvants
Kreuter, J., Liehl, E., Berg, U., et al. (1988) · Vaccine · doi:10.1016/0264-410x(88)90220-4 · Cited by 76
Tao, W., Mao, X., Davide, J. P., Ng, B., Cai, M., Burke, P. A., Sachs, A. B., & Sepp‐Lorenzino, L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.282 · Cited by 73
Hattori, K., Nishikawa, M., Watcharanurak, K., Ikoma, A., Kabashima, K., Toyota, H., Takahashi, Y., Takahashi, R., Watanabe, Y., & Takakura, Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900215 · Cited by 69
Effects of inhaled nanoparticles on acute lung injury induced by lipopolysaccharide in mice
Inoue, K.-I., Takano, H., Yanagisawa, R., Hirano, S., Kobayashi, T., Fujitani, Y., Shimada, A., & Yoshikawa, T. (2007) · Toxicology · doi:10.1016/j.tox.2007.05.022 · Cited by 69
Sequence determinants of innate immune activation by short interfering RNAs
Goodchild, A., Nopper, N., KING, A. G., Doan, T. B., Tanudji, M., Arndt, G. M., Poidinger, M., Rivory, L. P., & Passioura, T. (2009) · BMC Immunology · doi:10.1186/1471-2172-10-40 · Cited by 67
Khan, I. H., Krishnan, V. V., Ziman, M., Janatpour, K. A., Wun, T., Luciw, P. A., & Tuscano, J. M. (2008) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20452 · Cited by 65
Challenges and Opportunities for Local and Systemic Delivery of siRNA and Antisense Oligonucleotides
Sepp‐Lorenzino, L., & Ruddy, M. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.174 · Cited by 65
Moon, C., Park, H.-J., Choi, Y., Park, E., Castranova, V., & Kang, J. L. (2010) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390903486543 · Cited by 65
Aggravating Impact of Nanoparticles on Immune-Mediated Pulmonary Inflammation
Inoue, K., & Takano, H. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.44 · Cited by 63
PEG Nanocages as Non-sheddable Stabilizers for Drug Nanocrystals
Fuhrmann, K., Schulz, J. D., Gauthier, M. A., & Leroux, J. (2012) · ACS Nano · doi:10.1021/nn2046554 · Cited by 62
Zhang, K., Fang, H., Wang, Z., Li, Z., Taylor, J., & Wooley, K. L. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.10.033 · Cited by 60
Self-citationTGN1412—a regulator's perspective
Schneider, C. K., Kalinke, U., & Löwer, J. (2006) · Nature Biotechnology · doi:10.1038/nbt0506-493 · Cited by 60
Impact of Nanoparticles on the Immune System
Dwivedi, P. D., Tripathi, A., Ansari, K. M., Shanker, R., & Das, M. (2011) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2011.1264 · Cited by 60
Altered plasma levels of cytokines in patients with ischemic heart disease
Tashiro, H., Shimokawa, H., Yamamoto, K., Momohara, M., Tada, H., & Takeshita, A. (1997) · Coronary Artery Disease · doi:10.1097/00019501-199703000-00004 · Cited by 57
Moynagh, P. N. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1790139 · Cited by 57
Suppression of nanosilica particle-induced inflammation by surface modification of the particles
Morishige, T., Yoshioka, Y., Inakura, H., Tanabe, A., Narimatsu, S., Yao, X., Monobe, Y., Imazawa, T., Tsunoda, S., Tsutsumi, Y. M., et al. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0823-5 · Cited by 56
Shi, Y., Yadav, S. K., Wang, F., & Wang, H. (2010) · Journal of Toxicology and Environmental Health · doi:10.1080/15287391003614042 · Cited by 56
Circulating cytokine levels in mice with heart failure are etiology dependent
Vistnes, M., Wæhre, A., Nygård, S., Sjaastad, I., Andersson, K. B., Husberg, C., & Christensen, G. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01084.2009 · Cited by 50
In VivoEvaluation of pH-Sensitive Polymer-Based Immunoliposomes Targeting the CD33 Antigen
Simard, P., & Leroux, J. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900261m · Cited by 47
Nazmi, A., Dutta, K., & Basu, A. (2010) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000892 · Cited by 47
Rajananthanan, P., Attard, G. S., Sheikh, N. A., & Morrow, W. J. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00213-3 · Cited by 46
Kim, J. Y., Choung, S., Lee, E., Kim, Y. J., & Choi, Y. (2007) · Molecules and Cells · doi:10.1016/s1016-8478(23)07335-1 · Cited by 45
Lan, Q., Wang, S., Menashe, I., Armstrong, B. K., Zhang, Y., Hartge, P. A., Purdue, M. P., Holford, T. R., Morton, L. M., Kricker, A., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08424.x · Cited by 44
Rottembourg, D., Filippi, C. M., Bresson, D., Ehrhardt, K., Estes, E. A., Oldham, J. E., & von Herrath, M. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0803935 · Cited by 44
Effect of thiol functionalization on the hemo‐compatibility of PLGA nanoparticles
Thasneem, Y. M., Sajeesh, S., & Sharma, C. P. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.33220 · Cited by 44
Dendrosome-dendriplex inside liposomes: as a gene delivery system
Movassaghian, S., Moghimi, H. R., Shirazi, F. H., & Torchilin, V. P. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.628396 · Cited by 39
Effects of glucocorticoids on inflammation and arthritis
Morand, E. F. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32805e87d0 · Cited by 38
Zhang, K., Fang, H., Shen, G., Taylor, J., & Wooley, K. L. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200902-010aw · Cited by 34
Self-citationHuman Th9 cells: inflammatory cytokines modulate IL‐9 production through the induction of IL‐21
Ma, C. S., Tangye, S. G., & Deenick, E. K. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.73 · Cited by 33
Powers, M. R., Davies, M. H., & Eubanks, J. P. (2005) · Current Eye Research · doi:10.1080/02713680590923276 · Cited by 33
Hamdy, S. I., Haddadi, A., Somayaji, V., Ruan, D., & Samuel, J. (2007) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2007.03.010 · Cited by 30
The changes of T lymphocytes and cytokines in ICR mice fed with Fe3O4 magnetic nanoparticles
Chen, B. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s16176 · Cited by 28
Takayama, E. (2011) · Oncology Reports · doi:10.3892/or.2011.1258 · Cited by 23
Yoshida, H., Nishikawa, M., Yasuda, S., Mizuno, Y., Toyota, H., Kiyota, T., Takahashi, R., & Takakura, Y. (2009) · The Journal of Gene Medicine · doi:10.1002/jgm.1348 · Cited by 19
A Fluorescent Microsphere-Based Method for Assay of Multiple Analytes in Plasma
Bernhard, O. K., Mathias, R. A., Barnes, T. W., & Simpson, R. J. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-068-3_12 · Cited by 14
Cited by
Pharmacokinetic aspects of retinal drug delivery
del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.12.001 · Cited by 693
Metal Oxide Nanoparticles as Biomedical Materials
Nikolova, M. P., & Chavali, M. S. (2020) · Biomimetics · doi:10.3390/biomimetics5020027 · Cited by 510
Polymeric Nanostructures for Imaging and Therapy
Elsabahy, M., Heo, G. S., Lim, S.-M., Sun, G., & Wooley, K. L. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00135 · Cited by 508
Self-citationEFSA Scientific Committee, Hardy, A., Benford, D., Halldorsson, T., Jeger, M. J., Knutsen, H. K., More, S., Naegeli, H., Noteborn, H., Ockleford, C., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5327 · Cited by 416
Kus-Liśkiewicz, M., Fickers, P., & Ben Tahar, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010952 · Cited by 404
Metadata
- Authors
- Elsabahy, M., & Wooley, K. L.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 42
- Issue
- 12
- Pages
- 5552
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2167534105
- Cited by
- 407
- References
- 197
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.